GO:0042802 | identical protein binding | 24.36% (38/156) | 1.66 | 0.0 | 0.0 |
GO:0034059 | response to anoxia | 5.13% (8/156) | 4.56 | 0.0 | 3e-06 |
GO:0019511 | peptidyl-proline hydroxylation | 3.21% (5/156) | 6.2 | 0.0 | 3e-06 |
GO:0046872 | metal ion binding | 27.56% (43/156) | 1.35 | 0.0 | 3e-06 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 3.21% (5/156) | 6.29 | 0.0 | 3e-06 |
GO:0006091 | generation of precursor metabolites and energy | 9.62% (15/156) | 2.75 | 0.0 | 3e-06 |
GO:0043169 | cation binding | 27.56% (43/156) | 1.32 | 0.0 | 4e-06 |
GO:0070482 | response to oxygen levels | 10.26% (16/156) | 2.6 | 0.0 | 4e-06 |
GO:0043167 | ion binding | 36.54% (57/156) | 1.01 | 0.0 | 9e-06 |
GO:0044281 | small molecule metabolic process | 25.0% (39/156) | 1.35 | 0.0 | 9e-06 |
GO:0019842 | vitamin binding | 6.41% (10/156) | 3.42 | 0.0 | 9e-06 |
GO:0018126 | protein hydroxylation | 3.21% (5/156) | 5.71 | 0.0 | 1e-05 |
GO:0009061 | anaerobic respiration | 2.56% (4/156) | 6.51 | 0.0 | 1.4e-05 |
GO:0038199 | ethylene receptor activity | 2.56% (4/156) | 6.51 | 0.0 | 1.4e-05 |
GO:1901564 | organonitrogen compound metabolic process | 40.38% (63/156) | 0.89 | 0.0 | 2e-05 |
GO:0051740 | ethylene binding | 2.56% (4/156) | 6.27 | 0.0 | 2.4e-05 |
GO:0072328 | alkene binding | 2.56% (4/156) | 6.27 | 0.0 | 2.4e-05 |
GO:0003824 | catalytic activity | 53.21% (83/156) | 0.69 | 0.0 | 2.4e-05 |
GO:0036293 | response to decreased oxygen levels | 8.97% (14/156) | 2.48 | 0.0 | 2.6e-05 |
GO:0006532 | aspartate biosynthetic process | 1.92% (3/156) | 7.55 | 0.0 | 2.6e-05 |
GO:0006533 | aspartate catabolic process | 1.92% (3/156) | 7.55 | 0.0 | 2.6e-05 |
GO:0019550 | glutamate catabolic process to aspartate | 1.92% (3/156) | 7.55 | 0.0 | 2.6e-05 |
GO:0019551 | glutamate catabolic process to 2-oxoglutarate | 1.92% (3/156) | 7.55 | 0.0 | 2.6e-05 |
GO:0019752 | carboxylic acid metabolic process | 17.31% (27/156) | 1.58 | 0.0 | 3e-05 |
GO:0004656 | procollagen-proline 4-dioxygenase activity | 2.56% (4/156) | 6.16 | 0.0 | 3e-05 |
GO:0019798 | procollagen-proline dioxygenase activity | 2.56% (4/156) | 6.16 | 0.0 | 3e-05 |
GO:0030976 | thiamine pyrophosphate binding | 2.56% (4/156) | 6.06 | 0.0 | 3e-05 |
GO:0032868 | response to insulin | 4.49% (7/156) | 4.0 | 0.0 | 3.1e-05 |
GO:0044249 | cellular biosynthetic process | 29.49% (46/156) | 1.07 | 0.0 | 3.6e-05 |
GO:0070483 | detection of hypoxia | 2.56% (4/156) | 5.97 | 0.0 | 3.6e-05 |
GO:0031545 | peptidyl-proline 4-dioxygenase activity | 2.56% (4/156) | 5.97 | 0.0 | 3.6e-05 |
GO:0003032 | detection of oxygen | 2.56% (4/156) | 5.88 | 1e-06 | 4.2e-05 |
GO:0009727 | detection of ethylene stimulus | 2.56% (4/156) | 5.88 | 1e-06 | 4.2e-05 |
GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | 1.92% (3/156) | 7.23 | 1e-06 | 4.4e-05 |
GO:0006106 | fumarate metabolic process | 1.92% (3/156) | 7.23 | 1e-06 | 4.4e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 30.77% (48/156) | 1.03 | 1e-06 | 4.4e-05 |
GO:0043436 | oxoacid metabolic process | 18.59% (29/156) | 1.45 | 1e-06 | 4.5e-05 |
GO:0006082 | organic acid metabolic process | 19.23% (30/156) | 1.42 | 1e-06 | 4.5e-05 |
GO:0009058 | biosynthetic process | 31.41% (49/156) | 1.0 | 1e-06 | 4.5e-05 |
GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 4.49% (7/156) | 3.77 | 1e-06 | 5.7e-05 |
GO:0008152 | metabolic process | 58.97% (92/156) | 0.57 | 1e-06 | 5.7e-05 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 5.13% (8/156) | 3.41 | 1e-06 | 5.8e-05 |
GO:0046914 | transition metal ion binding | 13.46% (21/156) | 1.77 | 1e-06 | 5.8e-05 |
GO:0006094 | gluconeogenesis | 3.21% (5/156) | 4.8 | 1e-06 | 5.9e-05 |
GO:0016621 | cinnamoyl-CoA reductase activity | 2.56% (4/156) | 5.65 | 1e-06 | 6.4e-05 |
GO:0044237 | cellular metabolic process | 52.56% (82/156) | 0.63 | 1e-06 | 6.7e-05 |
GO:0031966 | mitochondrial membrane | 6.41% (10/156) | 2.87 | 1e-06 | 7.1e-05 |
GO:0031543 | peptidyl-proline dioxygenase activity | 2.56% (4/156) | 5.58 | 1e-06 | 7.4e-05 |
GO:0016491 | oxidoreductase activity | 17.95% (28/156) | 1.42 | 2e-06 | 8.3e-05 |
GO:0005829 | cytosol | 28.85% (45/156) | 1.02 | 2e-06 | 9.3e-05 |
GO:0043649 | dicarboxylic acid catabolic process | 2.56% (4/156) | 5.45 | 2e-06 | 0.0001 |
GO:0033800 | isoflavone 7-O-methyltransferase activity | 2.56% (4/156) | 5.45 | 2e-06 | 0.0001 |
GO:0006807 | nitrogen compound metabolic process | 45.51% (71/156) | 0.7 | 2e-06 | 0.0001 |
GO:0004737 | pyruvate decarboxylase activity | 1.92% (3/156) | 6.75 | 2e-06 | 0.0001 |
GO:0006531 | aspartate metabolic process | 1.92% (3/156) | 6.75 | 2e-06 | 0.0001 |
GO:2000904 | regulation of starch metabolic process | 3.85% (6/156) | 4.0 | 2e-06 | 0.0001 |
GO:1901698 | response to nitrogen compound | 14.74% (23/156) | 1.59 | 2e-06 | 0.000102 |
GO:0007565 | female pregnancy | 2.56% (4/156) | 5.38 | 2e-06 | 0.000107 |
GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.49% (7/156) | 3.55 | 3e-06 | 0.000111 |
GO:0009141 | nucleoside triphosphate metabolic process | 5.13% (8/156) | 3.22 | 3e-06 | 0.000113 |
GO:0010104 | regulation of ethylene-activated signaling pathway | 4.49% (7/156) | 3.52 | 3e-06 | 0.000115 |
GO:0070297 | regulation of phosphorelay signal transduction system | 4.49% (7/156) | 3.52 | 3e-06 | 0.000115 |
GO:0033729 | anthocyanidin reductase activity | 2.56% (4/156) | 5.33 | 3e-06 | 0.000117 |
GO:0019319 | hexose biosynthetic process | 3.21% (5/156) | 4.51 | 3e-06 | 0.000117 |
GO:0036094 | small molecule binding | 24.36% (38/156) | 1.12 | 3e-06 | 0.000118 |
GO:1901566 | organonitrogen compound biosynthetic process | 16.03% (25/156) | 1.47 | 4e-06 | 0.000137 |
GO:0009877 | nodulation | 3.85% (6/156) | 3.85 | 4e-06 | 0.000153 |
GO:0010243 | response to organonitrogen compound | 13.46% (21/156) | 1.64 | 4e-06 | 0.000153 |
GO:0019438 | aromatic compound biosynthetic process | 16.03% (25/156) | 1.46 | 4e-06 | 0.000158 |
GO:0009593 | detection of chemical stimulus | 5.13% (8/156) | 3.11 | 5e-06 | 0.000169 |
GO:0018158 | protein oxidation | 1.92% (3/156) | 6.38 | 5e-06 | 0.000182 |
GO:0018171 | peptidyl-cysteine oxidation | 1.92% (3/156) | 6.38 | 5e-06 | 0.000182 |
GO:0004673 | protein histidine kinase activity | 2.56% (4/156) | 5.06 | 6e-06 | 0.000212 |
GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor | 2.56% (4/156) | 5.06 | 6e-06 | 0.000212 |
GO:0030761 | 8-hydroxyquercitin 8-O-methyltransferase activity | 2.56% (4/156) | 5.01 | 7e-06 | 0.000237 |
GO:0014823 | response to activity | 2.56% (4/156) | 5.01 | 7e-06 | 0.000237 |
GO:0050997 | quaternary ammonium group binding | 2.56% (4/156) | 4.92 | 9e-06 | 0.000298 |
GO:0030766 | 11-O-demethyl-17-O-deacetylvindoline O-methyltransferase activity | 2.56% (4/156) | 4.92 | 9e-06 | 0.000298 |
GO:0019242 | methylglyoxal biosynthetic process | 1.92% (3/156) | 6.09 | 1e-05 | 0.000324 |
GO:0009987 | cellular process | 69.23% (108/156) | 0.41 | 1.1e-05 | 0.000354 |
GO:0050665 | hydrogen peroxide biosynthetic process | 2.56% (4/156) | 4.8 | 1.3e-05 | 0.000404 |
GO:0044706 | multi-multicellular organism process | 2.56% (4/156) | 4.8 | 1.3e-05 | 0.000404 |
GO:0071704 | organic substance metabolic process | 53.85% (84/156) | 0.54 | 1.3e-05 | 0.000406 |
GO:0014850 | response to muscle activity | 1.92% (3/156) | 5.97 | 1.3e-05 | 0.00041 |
GO:0008150 | biological_process | 77.56% (121/156) | 0.33 | 1.4e-05 | 0.000422 |
GO:1901362 | organic cyclic compound biosynthetic process | 17.31% (27/156) | 1.29 | 1.4e-05 | 0.000423 |
GO:0006520 | cellular amino acid metabolic process | 8.33% (13/156) | 2.08 | 1.4e-05 | 0.000424 |
GO:0047801 | L-cysteine transaminase activity | 1.28% (2/156) | 7.97 | 1.6e-05 | 0.000453 |
GO:0061609 | fructose-1-phosphate aldolase activity | 1.28% (2/156) | 7.97 | 1.6e-05 | 0.000453 |
GO:0030315 | T-tubule | 1.92% (3/156) | 5.85 | 1.7e-05 | 0.000485 |
GO:0009064 | glutamine family amino acid metabolic process | 3.85% (6/156) | 3.49 | 1.7e-05 | 0.000489 |
GO:0005515 | protein binding | 54.49% (85/156) | 0.52 | 1.8e-05 | 0.000496 |
GO:0042754 | negative regulation of circadian rhythm | 2.56% (4/156) | 4.65 | 2e-05 | 0.000535 |
GO:1903409 | reactive oxygen species biosynthetic process | 2.56% (4/156) | 4.65 | 2e-05 | 0.000535 |
GO:0044703 | multi-organism reproductive process | 2.56% (4/156) | 4.65 | 2e-05 | 0.000535 |
GO:0033799 | myricetin 3'-O-methyltransferase activity | 2.56% (4/156) | 4.61 | 2.2e-05 | 0.000585 |
GO:0006081 | cellular aldehyde metabolic process | 4.49% (7/156) | 3.06 | 2.3e-05 | 0.000607 |
GO:0006006 | glucose metabolic process | 3.21% (5/156) | 3.88 | 2.4e-05 | 0.000626 |
GO:0010186 | positive regulation of cellular defense response | 1.92% (3/156) | 5.65 | 2.7e-05 | 0.000671 |
GO:0009701 | isoflavonoid phytoalexin biosynthetic process | 1.92% (3/156) | 5.65 | 2.7e-05 | 0.000671 |
GO:0030746 | isoflavone 4'-O-methyltransferase activity | 1.92% (3/156) | 5.65 | 2.7e-05 | 0.000671 |
GO:0046289 | isoflavonoid phytoalexin metabolic process | 1.92% (3/156) | 5.65 | 2.7e-05 | 0.000671 |
GO:0006538 | glutamate catabolic process | 1.92% (3/156) | 5.65 | 2.7e-05 | 0.000671 |
GO:0043434 | response to peptide hormone | 4.49% (7/156) | 3.02 | 2.8e-05 | 0.000672 |
GO:0042803 | protein homodimerization activity | 10.26% (16/156) | 1.73 | 2.8e-05 | 0.000677 |
GO:0001666 | response to hypoxia | 7.05% (11/156) | 2.22 | 2.7e-05 | 0.000704 |
GO:0018208 | peptidyl-proline modification | 3.21% (5/156) | 3.82 | 3e-05 | 0.000716 |
GO:0048029 | monosaccharide binding | 3.21% (5/156) | 3.77 | 3.5e-05 | 0.00081 |
GO:0006096 | glycolytic process | 3.21% (5/156) | 3.77 | 3.5e-05 | 0.00081 |
GO:0006757 | ATP generation from ADP | 3.21% (5/156) | 3.77 | 3.5e-05 | 0.00081 |
GO:0016830 | carbon-carbon lyase activity | 4.49% (7/156) | 2.97 | 3.5e-05 | 0.000824 |
GO:1901360 | organic cyclic compound metabolic process | 29.49% (46/156) | 0.84 | 3.8e-05 | 0.000856 |
GO:0006536 | glutamate metabolic process | 2.56% (4/156) | 4.41 | 3.8e-05 | 0.000859 |
GO:0010185 | regulation of cellular defense response | 1.92% (3/156) | 5.47 | 4.1e-05 | 0.00091 |
GO:0046031 | ADP metabolic process | 3.21% (5/156) | 3.72 | 4.1e-05 | 0.000913 |
GO:1901681 | sulfur compound binding | 3.85% (6/156) | 3.25 | 4.4e-05 | 0.00096 |
GO:0050077 | maleylpyruvate isomerase activity | 1.28% (2/156) | 7.38 | 4.7e-05 | 0.000997 |
GO:1901170 | naphthalene catabolic process | 1.28% (2/156) | 7.38 | 4.7e-05 | 0.000997 |
GO:0005344 | oxygen carrier activity | 1.28% (2/156) | 7.38 | 4.7e-05 | 0.000997 |
GO:0015669 | gas transport | 1.28% (2/156) | 7.38 | 4.7e-05 | 0.000997 |
GO:0015671 | oxygen transport | 1.28% (2/156) | 7.38 | 4.7e-05 | 0.000997 |
GO:0031406 | carboxylic acid binding | 3.85% (6/156) | 3.21 | 5e-05 | 0.001049 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 3.21% (5/156) | 3.65 | 5.3e-05 | 0.001082 |
GO:0009812 | flavonoid metabolic process | 6.41% (10/156) | 2.26 | 5.3e-05 | 0.001091 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 3.21% (5/156) | 3.63 | 5.5e-05 | 0.001126 |
GO:0009717 | isoflavonoid biosynthetic process | 2.56% (4/156) | 4.27 | 5.7e-05 | 0.001142 |
GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity | 2.56% (4/156) | 4.27 | 5.7e-05 | 0.001142 |
GO:0007595 | lactation | 1.92% (3/156) | 5.31 | 5.8e-05 | 0.001148 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.77% (9/156) | 2.39 | 6.2e-05 | 0.001231 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 3.21% (5/156) | 3.59 | 6.4e-05 | 0.001245 |
GO:0046983 | protein dimerization activity | 11.54% (18/156) | 1.51 | 6.4e-05 | 0.001252 |
GO:0006107 | oxaloacetate metabolic process | 1.92% (3/156) | 5.23 | 6.8e-05 | 0.001305 |
GO:1901576 | organic substance biosynthetic process | 26.92% (42/156) | 0.86 | 6.8e-05 | 0.001306 |
GO:0006165 | nucleoside diphosphate phosphorylation | 3.21% (5/156) | 3.55 | 7.3e-05 | 0.001372 |
GO:0046364 | monosaccharide biosynthetic process | 3.21% (5/156) | 3.55 | 7.3e-05 | 0.001372 |
GO:0043177 | organic acid binding | 3.85% (6/156) | 3.11 | 7.5e-05 | 0.001399 |
GO:0005488 | binding | 65.38% (102/156) | 0.39 | 7.8e-05 | 0.001406 |
GO:0044283 | small molecule biosynthetic process | 11.54% (18/156) | 1.49 | 7.7e-05 | 0.001407 |
GO:0009408 | response to heat | 8.97% (14/156) | 1.76 | 7.7e-05 | 0.001415 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3.85% (6/156) | 3.1 | 7.7e-05 | 0.001423 |
GO:0005507 | copper ion binding | 4.49% (7/156) | 2.79 | 7.7e-05 | 0.001433 |
GO:0016831 | carboxy-lyase activity | 3.21% (5/156) | 3.51 | 8.3e-05 | 0.001488 |
GO:0043204 | perikaryon | 2.56% (4/156) | 4.11 | 8.8e-05 | 0.00156 |
GO:0046939 | nucleotide phosphorylation | 3.21% (5/156) | 3.48 | 9e-05 | 0.001598 |
GO:1901605 | alpha-amino acid metabolic process | 6.41% (10/156) | 2.16 | 9.1e-05 | 0.001601 |
GO:0016034 | maleylacetoacetate isomerase activity | 1.28% (2/156) | 6.97 | 9.4e-05 | 0.001626 |
GO:0043097 | pyrimidine nucleoside salvage | 1.28% (2/156) | 6.97 | 9.4e-05 | 0.001626 |
GO:0046287 | isoflavonoid metabolic process | 2.56% (4/156) | 4.09 | 9.4e-05 | 0.001634 |
GO:0009259 | ribonucleotide metabolic process | 5.77% (9/156) | 2.31 | 9.7e-05 | 0.001664 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 3.85% (6/156) | 3.04 | 9.9e-05 | 0.001674 |
GO:1901606 | alpha-amino acid catabolic process | 3.85% (6/156) | 3.03 | 0.000102 | 0.001713 |
GO:0009068 | aspartate family amino acid catabolic process | 1.92% (3/156) | 5.03 | 0.000104 | 0.001746 |
GO:0080110 | sporopollenin biosynthetic process | 2.56% (4/156) | 4.04 | 0.000107 | 0.001754 |
GO:0009720 | detection of hormone stimulus | 2.56% (4/156) | 4.04 | 0.000107 | 0.001754 |
GO:0009726 | detection of endogenous stimulus | 2.56% (4/156) | 4.04 | 0.000107 | 0.001754 |
GO:0046483 | heterocycle metabolic process | 24.36% (38/156) | 0.89 | 0.000108 | 0.001761 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 5.77% (9/156) | 2.28 | 0.000111 | 0.001801 |
GO:0019693 | ribose phosphate metabolic process | 5.77% (9/156) | 2.27 | 0.000116 | 0.001878 |
GO:0016853 | isomerase activity | 5.13% (8/156) | 2.45 | 0.000119 | 0.001911 |
GO:0009699 | phenylpropanoid biosynthetic process | 8.33% (13/156) | 1.77 | 0.000125 | 0.001996 |
GO:0007589 | body fluid secretion | 1.92% (3/156) | 4.91 | 0.000134 | 0.002115 |
GO:0043173 | nucleotide salvage | 1.92% (3/156) | 4.91 | 0.000134 | 0.002115 |
GO:0110165 | cellular anatomical entity | 74.36% (116/156) | 0.31 | 0.000137 | 0.002143 |
GO:0009132 | nucleoside diphosphate metabolic process | 3.21% (5/156) | 3.31 | 0.000157 | 0.002289 |
GO:0004818 | glutamate-tRNA ligase activity | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0004827 | proline-tRNA ligase activity | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0006424 | glutamyl-tRNA aminoacylation | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:1903958 | nitric-oxide synthase complex | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0000253 | 3-keto sterol reductase activity | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0043011 | myeloid dendritic cell differentiation | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0097028 | dendritic cell differentiation | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0004845 | uracil phosphoribosyltransferase activity | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0044211 | CTP salvage | 1.28% (2/156) | 6.65 | 0.000157 | 0.002299 |
GO:0009063 | cellular amino acid catabolic process | 3.85% (6/156) | 2.91 | 0.00016 | 0.002316 |
GO:0009698 | phenylpropanoid metabolic process | 8.97% (14/156) | 1.66 | 0.000152 | 0.002368 |
GO:0009438 | methylglyoxal metabolic process | 1.92% (3/156) | 4.8 | 0.00017 | 0.002406 |
GO:0009065 | glutamine family amino acid catabolic process | 1.92% (3/156) | 4.8 | 0.00017 | 0.002406 |
GO:0005741 | mitochondrial outer membrane | 3.21% (5/156) | 3.29 | 0.000169 | 0.002422 |
GO:0050896 | response to stimulus | 53.21% (83/156) | 0.46 | 0.000168 | 0.002424 |
GO:0046184 | aldehyde biosynthetic process | 2.56% (4/156) | 3.84 | 0.000182 | 0.002553 |
GO:0043094 | cellular metabolic compound salvage | 3.21% (5/156) | 3.27 | 0.000182 | 0.002561 |
GO:0001889 | liver development | 3.21% (5/156) | 3.25 | 0.000195 | 0.00272 |
GO:0002237 | response to molecule of bacterial origin | 5.77% (9/156) | 2.15 | 0.000218 | 0.003015 |
GO:1901652 | response to peptide | 4.49% (7/156) | 2.54 | 0.000219 | 0.00302 |
GO:0001773 | myeloid dendritic cell activation | 1.28% (2/156) | 6.38 | 0.000235 | 0.003201 |
GO:0044206 | UMP salvage | 1.28% (2/156) | 6.38 | 0.000235 | 0.003201 |
GO:0097159 | organic cyclic compound binding | 37.82% (59/156) | 0.6 | 0.000239 | 0.003237 |
GO:0009725 | response to hormone | 21.15% (33/156) | 0.91 | 0.000245 | 0.003304 |
GO:0032869 | cellular response to insulin stimulus | 2.56% (4/156) | 3.72 | 0.00025 | 0.003359 |
GO:0018130 | heterocycle biosynthetic process | 11.54% (18/156) | 1.35 | 0.000266 | 0.00355 |
GO:0043650 | dicarboxylic acid biosynthetic process | 2.56% (4/156) | 3.68 | 0.000277 | 0.003673 |
GO:0007631 | feeding behavior | 1.92% (3/156) | 4.55 | 0.000284 | 0.00375 |
GO:0008171 | O-methyltransferase activity | 3.21% (5/156) | 3.1 | 0.000312 | 0.00405 |
GO:0005743 | mitochondrial inner membrane | 3.21% (5/156) | 3.1 | 0.000312 | 0.00405 |
GO:0005575 | cellular_component | 74.36% (116/156) | 0.29 | 0.000308 | 0.004052 |
GO:0070061 | fructose binding | 1.28% (2/156) | 6.16 | 0.000328 | 0.004243 |
GO:0006090 | pyruvate metabolic process | 3.21% (5/156) | 3.08 | 0.000332 | 0.004268 |
GO:0006103 | 2-oxoglutarate metabolic process | 1.92% (3/156) | 4.47 | 0.000341 | 0.004363 |
GO:0071375 | cellular response to peptide hormone stimulus | 2.56% (4/156) | 3.59 | 0.000351 | 0.004472 |
GO:0016854 | racemase and epimerase activity | 2.56% (4/156) | 3.58 | 0.000367 | 0.004658 |
GO:0006071 | glycerol metabolic process | 1.92% (3/156) | 4.42 | 0.000372 | 0.004664 |
GO:1901363 | heterocyclic compound binding | 37.18% (58/156) | 0.59 | 0.000371 | 0.004674 |
GO:0006631 | fatty acid metabolic process | 7.05% (11/156) | 1.79 | 0.000388 | 0.004819 |
GO:0005506 | iron ion binding | 5.13% (8/156) | 2.2 | 0.000388 | 0.004841 |
GO:0014072 | response to isoquinoline alkaloid | 1.92% (3/156) | 4.34 | 0.000439 | 0.005149 |
GO:0043278 | response to morphine | 1.92% (3/156) | 4.34 | 0.000439 | 0.005149 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 7.05% (11/156) | 1.76 | 0.000444 | 0.005161 |
GO:0009266 | response to temperature stimulus | 14.1% (22/156) | 1.13 | 0.000442 | 0.005168 |
GO:0031166 | integral component of vacuolar membrane | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0031310 | intrinsic component of vacuolar membrane | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0071627 | integral component of fungal-type vacuolar membrane | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0071628 | intrinsic component of fungal-type vacuolar membrane | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0050421 | nitrite reductase (NO-forming) activity | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0006114 | glycerol biosynthetic process | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0004849 | uridine kinase activity | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0010138 | pyrimidine ribonucleotide salvage | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0032262 | pyrimidine nucleotide salvage | 1.28% (2/156) | 5.97 | 0.000436 | 0.00517 |
GO:0019400 | alditol metabolic process | 1.92% (3/156) | 4.31 | 0.000475 | 0.005498 |
GO:0009117 | nucleotide metabolic process | 6.41% (10/156) | 1.85 | 0.000503 | 0.00572 |
GO:0051262 | protein tetramerization | 3.21% (5/156) | 2.95 | 0.000501 | 0.005728 |
GO:1901607 | alpha-amino acid biosynthetic process | 4.49% (7/156) | 2.35 | 0.000497 | 0.005733 |
GO:0032787 | monocarboxylic acid metabolic process | 10.26% (16/156) | 1.37 | 0.000501 | 0.005752 |
GO:0031418 | L-ascorbic acid binding | 1.92% (3/156) | 4.27 | 0.000513 | 0.005807 |
GO:0046034 | ATP metabolic process | 3.21% (5/156) | 2.93 | 0.00053 | 0.005976 |
GO:0006950 | response to stress | 40.38% (63/156) | 0.53 | 0.000561 | 0.006162 |
GO:0097452 | GAIT complex | 1.28% (2/156) | 5.8 | 0.000559 | 0.00617 |
GO:0060776 | simple leaf morphogenesis | 1.28% (2/156) | 5.8 | 0.000559 | 0.00617 |
GO:0019401 | alditol biosynthetic process | 1.28% (2/156) | 5.8 | 0.000559 | 0.00617 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 1.28% (2/156) | 5.8 | 0.000559 | 0.00617 |
GO:0035686 | sperm fibrous sheath | 1.28% (2/156) | 5.8 | 0.000559 | 0.00617 |
GO:0006753 | nucleoside phosphate metabolic process | 6.41% (10/156) | 1.83 | 0.000574 | 0.006275 |
GO:0009861 | jasmonic acid and ethylene-dependent systemic resistance | 1.92% (3/156) | 4.2 | 0.000595 | 0.006475 |
GO:0009611 | response to wounding | 9.62% (15/156) | 1.4 | 0.000605 | 0.006559 |
GO:0005996 | monosaccharide metabolic process | 3.85% (6/156) | 2.55 | 0.000608 | 0.006569 |
GO:0042180 | cellular ketone metabolic process | 3.21% (5/156) | 2.86 | 0.000658 | 0.00707 |
GO:0044282 | small molecule catabolic process | 5.77% (9/156) | 1.92 | 0.000673 | 0.007209 |
GO:0018198 | peptidyl-cysteine modification | 1.92% (3/156) | 4.13 | 0.000684 | 0.007297 |
GO:0052650 | NADP-retinol dehydrogenase activity | 1.28% (2/156) | 5.65 | 0.000697 | 0.007373 |
GO:0043174 | nucleoside salvage | 1.28% (2/156) | 5.65 | 0.000697 | 0.007373 |
GO:0046395 | carboxylic acid catabolic process | 4.49% (7/156) | 2.26 | 0.000715 | 0.007533 |
GO:0043279 | response to alkaloid | 2.56% (4/156) | 3.3 | 0.000766 | 0.008028 |
GO:0009719 | response to endogenous stimulus | 21.15% (33/156) | 0.82 | 0.000814 | 0.008495 |
GO:0050661 | NADP binding | 3.21% (5/156) | 2.79 | 0.000827 | 0.008601 |
GO:0098809 | nitrite reductase activity | 1.28% (2/156) | 5.51 | 0.00085 | 0.008734 |
GO:0019825 | oxygen binding | 1.28% (2/156) | 5.51 | 0.00085 | 0.008734 |
GO:0004332 | fructose-bisphosphate aldolase activity | 1.28% (2/156) | 5.51 | 0.00085 | 0.008734 |
GO:0051213 | dioxygenase activity | 4.49% (7/156) | 2.21 | 0.000863 | 0.008831 |
GO:0009733 | response to auxin | 7.69% (12/156) | 1.55 | 0.000885 | 0.00902 |
GO:0051606 | detection of stimulus | 5.13% (8/156) | 2.01 | 0.000909 | 0.009227 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 4.49% (7/156) | 2.2 | 0.000917 | 0.009274 |
GO:0005782 | peroxisomal matrix | 1.92% (3/156) | 3.97 | 0.000945 | 0.009483 |
GO:0031907 | microbody lumen | 1.92% (3/156) | 3.97 | 0.000945 | 0.009483 |
GO:0032881 | regulation of polysaccharide metabolic process | 3.85% (6/156) | 2.42 | 0.000966 | 0.009657 |
GO:0019318 | hexose metabolic process | 3.21% (5/156) | 2.73 | 0.001003 | 0.009986 |
GO:0140212 | regulation of long-chain fatty acid import into cell | 1.28% (2/156) | 5.38 | 0.001017 | 0.010048 |
GO:0004090 | carbonyl reductase (NADPH) activity | 1.28% (2/156) | 5.38 | 0.001017 | 0.010048 |
GO:0010105 | negative regulation of ethylene-activated signaling pathway | 2.56% (4/156) | 3.17 | 0.001049 | 0.010285 |
GO:0070298 | negative regulation of phosphorelay signal transduction system | 2.56% (4/156) | 3.17 | 0.001049 | 0.010285 |
GO:0003674 | molecular_function | 71.79% (112/156) | 0.26 | 0.001143 | 0.01116 |
GO:0051289 | protein homotetramerization | 2.56% (4/156) | 3.14 | 0.001159 | 0.011267 |
GO:2000191 | regulation of fatty acid transport | 1.28% (2/156) | 5.27 | 0.001199 | 0.011531 |
GO:0048678 | response to axon injury | 1.28% (2/156) | 5.27 | 0.001199 | 0.011531 |
GO:0000792 | heterochromatin | 2.56% (4/156) | 3.12 | 0.001197 | 0.011593 |
GO:0034754 | cellular hormone metabolic process | 4.49% (7/156) | 2.13 | 0.001212 | 0.011613 |
GO:0008652 | cellular amino acid biosynthetic process | 4.49% (7/156) | 2.12 | 0.00123 | 0.011735 |
GO:0030018 | Z disc | 1.92% (3/156) | 3.83 | 0.001262 | 0.011997 |
GO:0016054 | organic acid catabolic process | 4.49% (7/156) | 2.1 | 0.00132 | 0.012499 |
GO:0048732 | gland development | 3.21% (5/156) | 2.63 | 0.001347 | 0.012714 |
GO:0006522 | alanine metabolic process | 1.28% (2/156) | 5.16 | 0.001396 | 0.01293 |
GO:0009078 | pyruvate family amino acid metabolic process | 1.28% (2/156) | 5.16 | 0.001396 | 0.01293 |
GO:0006222 | UMP biosynthetic process | 1.28% (2/156) | 5.16 | 0.001396 | 0.01293 |
GO:0009174 | pyrimidine ribonucleoside monophosphate biosynthetic process | 1.28% (2/156) | 5.16 | 0.001396 | 0.01293 |
GO:0044238 | primary metabolic process | 43.59% (68/156) | 0.45 | 0.001379 | 0.012967 |
GO:0010162 | seed dormancy process | 2.56% (4/156) | 3.04 | 0.001488 | 0.013737 |
GO:0009150 | purine ribonucleotide metabolic process | 4.49% (7/156) | 2.06 | 0.001577 | 0.014509 |
GO:0120253 | hydrocarbon catabolic process | 1.28% (2/156) | 5.06 | 0.001606 | 0.014511 |
GO:0008121 | ubiquinol-cytochrome-c reductase activity | 1.28% (2/156) | 5.06 | 0.001606 | 0.014511 |
GO:0001758 | retinal dehydrogenase activity | 1.28% (2/156) | 5.06 | 0.001606 | 0.014511 |
GO:0002168 | instar larval development | 1.28% (2/156) | 5.06 | 0.001606 | 0.014511 |
GO:0019206 | nucleoside kinase activity | 1.28% (2/156) | 5.06 | 0.001606 | 0.014511 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.92% (3/156) | 3.67 | 0.001721 | 0.015493 |
GO:0043648 | dicarboxylic acid metabolic process | 3.21% (5/156) | 2.54 | 0.001771 | 0.015891 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1.92% (3/156) | 3.65 | 0.001806 | 0.016147 |
GO:0008201 | heparin binding | 1.28% (2/156) | 4.97 | 0.001831 | 0.016196 |
GO:0046049 | UMP metabolic process | 1.28% (2/156) | 4.97 | 0.001831 | 0.016196 |
GO:0035094 | response to nicotine | 1.28% (2/156) | 4.97 | 0.001831 | 0.016196 |
GO:0034641 | cellular nitrogen compound metabolic process | 22.44% (35/156) | 0.72 | 0.00184 | 0.01622 |
GO:0016832 | aldehyde-lyase activity | 1.92% (3/156) | 3.62 | 0.001894 | 0.016641 |
GO:0016226 | iron-sulfur cluster assembly | 1.92% (3/156) | 3.6 | 0.001985 | 0.017317 |
GO:0031163 | metallo-sulfur cluster assembly | 1.92% (3/156) | 3.6 | 0.001985 | 0.017317 |
GO:0010200 | response to chitin | 6.41% (10/156) | 1.59 | 0.001992 | 0.017323 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 10.9% (17/156) | 1.13 | 0.002011 | 0.017431 |
GO:0006163 | purine nucleotide metabolic process | 4.49% (7/156) | 2.0 | 0.002023 | 0.01747 |
GO:0006116 | NADH oxidation | 1.28% (2/156) | 4.88 | 0.002069 | 0.017813 |
GO:0080147 | root hair cell development | 2.56% (4/156) | 2.9 | 0.002097 | 0.017987 |
GO:0006066 | alcohol metabolic process | 4.49% (7/156) | 1.98 | 0.002182 | 0.018655 |
GO:0009628 | response to abiotic stimulus | 28.85% (45/156) | 0.59 | 0.002216 | 0.018887 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0042574 | retinal metabolic process | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0006241 | CTP biosynthetic process | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0008655 | pyrimidine-containing compound salvage | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0009163 | nucleoside biosynthetic process | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0046036 | CTP metabolic process | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0070070 | proton-transporting V-type ATPase complex assembly | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 1.28% (2/156) | 4.8 | 0.002322 | 0.019146 |
GO:0009067 | aspartate family amino acid biosynthetic process | 1.92% (3/156) | 3.53 | 0.002272 | 0.019298 |
GO:0016829 | lyase activity | 6.41% (10/156) | 1.55 | 0.002363 | 0.019426 |
GO:0102934 | costunolide synthase activity | 1.92% (3/156) | 3.51 | 0.002373 | 0.019445 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.92% (3/156) | 3.49 | 0.002477 | 0.020232 |
GO:0006457 | protein folding | 3.85% (6/156) | 2.15 | 0.002492 | 0.020285 |
GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors | 1.28% (2/156) | 4.72 | 0.002588 | 0.020804 |
GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process | 1.28% (2/156) | 4.72 | 0.002588 | 0.020804 |
GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process | 1.28% (2/156) | 4.72 | 0.002588 | 0.020804 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 1.28% (2/156) | 4.72 | 0.002588 | 0.020804 |
GO:0018193 | peptidyl-amino acid modification | 7.05% (11/156) | 1.44 | 0.002653 | 0.020994 |
GO:0052482 | defense response by cell wall thickening | 2.56% (4/156) | 2.81 | 0.002653 | 0.021056 |
GO:0052544 | defense response by callose deposition in cell wall | 2.56% (4/156) | 2.81 | 0.002653 | 0.021056 |
GO:0009821 | alkaloid biosynthetic process | 3.85% (6/156) | 2.13 | 0.002641 | 0.021091 |
GO:0042221 | response to chemical | 34.62% (54/156) | 0.5 | 0.002636 | 0.021124 |
GO:0031968 | organelle outer membrane | 3.21% (5/156) | 2.4 | 0.002701 | 0.021303 |
GO:0016051 | carbohydrate biosynthetic process | 5.13% (8/156) | 1.75 | 0.002767 | 0.021764 |
GO:0045333 | cellular respiration | 2.56% (4/156) | 2.79 | 0.002789 | 0.021797 |
GO:0022611 | dormancy process | 2.56% (4/156) | 2.79 | 0.002789 | 0.021797 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.92% (3/156) | 3.42 | 0.002806 | 0.0218 |
GO:0019867 | outer membrane | 3.21% (5/156) | 2.39 | 0.0028 | 0.021815 |
GO:0002165 | instar larval or pupal development | 1.28% (2/156) | 4.65 | 0.002868 | 0.02208 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.28% (2/156) | 4.65 | 0.002868 | 0.02208 |
GO:0042743 | hydrogen peroxide metabolic process | 2.56% (4/156) | 2.78 | 0.002859 | 0.022138 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.92% (3/156) | 3.4 | 0.002922 | 0.022423 |
GO:0022900 | electron transport chain | 3.21% (5/156) | 2.37 | 0.002953 | 0.022597 |
GO:1901653 | cellular response to peptide | 2.56% (4/156) | 2.76 | 0.003002 | 0.022899 |
GO:0043168 | anion binding | 15.38% (24/156) | 0.86 | 0.003075 | 0.023392 |
GO:0030955 | potassium ion binding | 1.28% (2/156) | 4.58 | 0.003162 | 0.023907 |
GO:0009173 | pyrimidine ribonucleoside monophosphate metabolic process | 1.28% (2/156) | 4.58 | 0.003162 | 0.023907 |
GO:0008483 | transaminase activity | 1.92% (3/156) | 3.34 | 0.003285 | 0.02469 |
GO:0015908 | fatty acid transport | 1.92% (3/156) | 3.34 | 0.003285 | 0.02469 |
GO:0031974 | membrane-enclosed lumen | 6.41% (10/156) | 1.48 | 0.003325 | 0.024772 |
GO:0043233 | organelle lumen | 6.41% (10/156) | 1.48 | 0.003325 | 0.024772 |
GO:0070013 | intracellular organelle lumen | 6.41% (10/156) | 1.48 | 0.003325 | 0.024772 |
GO:0016769 | transferase activity, transferring nitrogenous groups | 1.92% (3/156) | 3.33 | 0.003412 | 0.025345 |
GO:0018992 | germ-line sex determination | 1.28% (2/156) | 4.51 | 0.003469 | 0.025621 |
GO:0080026 | response to indolebutyric acid | 1.28% (2/156) | 4.51 | 0.003469 | 0.025621 |
GO:0005543 | phospholipid binding | 3.85% (6/156) | 2.05 | 0.003486 | 0.025673 |
GO:0008168 | methyltransferase activity | 4.49% (7/156) | 1.85 | 0.003544 | 0.026024 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3.21% (5/156) | 2.3 | 0.00369 | 0.027016 |
GO:0034975 | protein folding in endoplasmic reticulum | 1.28% (2/156) | 4.45 | 0.00379 | 0.027509 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 1.28% (2/156) | 4.45 | 0.00379 | 0.027509 |
GO:0019856 | pyrimidine nucleobase biosynthetic process | 1.28% (2/156) | 4.45 | 0.00379 | 0.027509 |
GO:0008949 | oxalyl-CoA decarboxylase activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0097089 | methyl-branched fatty acid metabolic process | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0106359 | 2-hydroxyacyl-CoA lyase activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0106360 | 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:1903512 | phytanic acid metabolic process | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0010260 | obsolete animal organ senescence | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0004357 | glutamate-cysteine ligase activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0008824 | cyanate hydratase activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0052684 | L-serine hydro-lyase (adding indole, L-tryptophan-forming) activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0000906 | 6,7-dimethyl-8-ribityllumazine synthase activity | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0009349 | riboflavin synthase complex | 0.64% (1/156) | 7.97 | 0.003991 | 0.027784 |
GO:0032890 | regulation of organic acid transport | 1.28% (2/156) | 4.38 | 0.004123 | 0.028318 |
GO:0071346 | cellular response to interferon-gamma | 1.28% (2/156) | 4.38 | 0.004123 | 0.028318 |
GO:0002274 | myeloid leukocyte activation | 1.28% (2/156) | 4.38 | 0.004123 | 0.028318 |
GO:0006000 | fructose metabolic process | 1.28% (2/156) | 4.38 | 0.004123 | 0.028318 |
GO:0043462 | regulation of ATP-dependent activity | 1.92% (3/156) | 3.23 | 0.004092 | 0.028407 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 3.85% (6/156) | 2.01 | 0.003926 | 0.028422 |
GO:0019748 | secondary metabolic process | 10.26% (16/156) | 1.08 | 0.003968 | 0.028639 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 2.56% (4/156) | 2.62 | 0.004234 | 0.029002 |
GO:0016741 | transferase activity, transferring one-carbon groups | 4.49% (7/156) | 1.8 | 0.004314 | 0.029392 |
GO:0005783 | endoplasmic reticulum | 9.62% (15/156) | 1.11 | 0.004311 | 0.029452 |
GO:0031420 | alkali metal ion binding | 1.28% (2/156) | 4.33 | 0.00447 | 0.030212 |
GO:0005986 | sucrose biosynthetic process | 1.28% (2/156) | 4.33 | 0.00447 | 0.030212 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 1.28% (2/156) | 4.33 | 0.00447 | 0.030212 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.92% (3/156) | 3.16 | 0.00469 | 0.031534 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.92% (3/156) | 3.16 | 0.00469 | 0.031534 |
GO:0044550 | secondary metabolite biosynthetic process | 8.33% (13/156) | 1.2 | 0.004716 | 0.031619 |
GO:0009165 | nucleotide biosynthetic process | 3.21% (5/156) | 2.21 | 0.004767 | 0.031877 |
GO:0006809 | nitric oxide biosynthetic process | 1.28% (2/156) | 4.27 | 0.00483 | 0.032049 |
GO:0046209 | nitric oxide metabolic process | 1.28% (2/156) | 4.27 | 0.00483 | 0.032049 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 1.28% (2/156) | 4.27 | 0.00483 | 0.032049 |
GO:0009864 | induced systemic resistance, jasmonic acid mediated signaling pathway | 1.92% (3/156) | 3.14 | 0.004848 | 0.032085 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.77% (9/156) | 1.5 | 0.005006 | 0.033044 |
GO:1901293 | nucleoside phosphate biosynthetic process | 3.21% (5/156) | 2.18 | 0.005145 | 0.033872 |
GO:0009739 | response to gibberellin | 3.85% (6/156) | 1.93 | 0.005175 | 0.033895 |
GO:0050878 | regulation of body fluid levels | 1.92% (3/156) | 3.11 | 0.005173 | 0.033968 |
GO:0005154 | epidermal growth factor receptor binding | 1.28% (2/156) | 4.21 | 0.005203 | 0.033992 |
GO:0016740 | transferase activity | 23.08% (36/156) | 0.61 | 0.005288 | 0.034458 |
GO:0009625 | response to insect | 2.56% (4/156) | 2.53 | 0.005329 | 0.03455 |
GO:0052543 | callose deposition in cell wall | 2.56% (4/156) | 2.53 | 0.005329 | 0.03455 |
GO:0090332 | stomatal closure | 1.92% (3/156) | 3.08 | 0.00551 | 0.035633 |
GO:0048520 | positive regulation of behavior | 1.28% (2/156) | 4.11 | 0.005987 | 0.038618 |
GO:0016597 | amino acid binding | 1.92% (3/156) | 3.03 | 0.00604 | 0.038865 |
GO:0106223 | germacrene A hydroxylase activity | 1.92% (3/156) | 3.0 | 0.00641 | 0.040833 |
GO:0034341 | response to interferon-gamma | 1.28% (2/156) | 4.06 | 0.006398 | 0.040855 |
GO:0005539 | glycosaminoglycan binding | 1.28% (2/156) | 4.06 | 0.006398 | 0.040855 |
GO:0071467 | cellular response to pH | 1.28% (2/156) | 4.06 | 0.006398 | 0.040855 |
GO:0030246 | carbohydrate binding | 3.21% (5/156) | 2.1 | 0.006497 | 0.04128 |
GO:0072521 | purine-containing compound metabolic process | 4.49% (7/156) | 1.68 | 0.006536 | 0.04143 |
GO:0052386 | cell wall thickening | 2.56% (4/156) | 2.44 | 0.006599 | 0.04172 |
GO:1901141 | regulation of lignin biosynthetic process | 2.56% (4/156) | 2.43 | 0.006723 | 0.042402 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 1.28% (2/156) | 4.01 | 0.006821 | 0.042914 |
GO:0052542 | defense response by callose deposition | 2.56% (4/156) | 2.41 | 0.006977 | 0.043677 |
GO:0009260 | ribonucleotide biosynthetic process | 2.56% (4/156) | 2.41 | 0.006977 | 0.043677 |
GO:0009624 | response to nematode | 2.56% (4/156) | 2.41 | 0.007106 | 0.044377 |
GO:0015980 | energy derivation by oxidation of organic compounds | 2.56% (4/156) | 2.4 | 0.007237 | 0.045083 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.28% (2/156) | 3.97 | 0.007257 | 0.045099 |
GO:0008343 | adult feeding behavior | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0033611 | oxalate catabolic process | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0015930 | glutamate synthase activity | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0016040 | glutamate synthase (NADH) activity | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0016041 | glutamate synthase (ferredoxin) activity | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0016643 | oxidoreductase activity, acting on the CH-NH2 group of donors, iron-sulfur protein as acceptor | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0045181 | glutamate synthase activity, NAD(P)H as acceptor | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0080114 | positive regulation of glycine hydroxymethyltransferase activity | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0010832 | negative regulation of myotube differentiation | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0061734 | parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0070844 | polyubiquitinated protein transport | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0070845 | polyubiquitinated misfolded protein transport | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:1901033 | positive regulation of response to reactive oxygen species | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:1905206 | positive regulation of hydrogen peroxide-induced cell death | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:1990342 | heterochromatin island | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0019470 | 4-hydroxyproline catabolic process | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0019471 | 4-hydroxyproline metabolic process | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0004618 | phosphoglycerate kinase activity | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:1990845 | adaptive thermogenesis | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0009439 | cyanate metabolic process | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:0009440 | cyanate catabolic process | 0.64% (1/156) | 6.97 | 0.007966 | 0.046236 |
GO:1900425 | negative regulation of defense response to bacterium | 2.56% (4/156) | 2.38 | 0.007503 | 0.046513 |
GO:1902532 | negative regulation of intracellular signal transduction | 3.85% (6/156) | 1.81 | 0.007645 | 0.047165 |
GO:0044255 | cellular lipid metabolic process | 11.54% (18/156) | 0.91 | 0.007629 | 0.047181 |
GO:0035613 | RNA stem-loop binding | 1.28% (2/156) | 3.92 | 0.007705 | 0.047193 |
GO:0006213 | pyrimidine nucleoside metabolic process | 1.28% (2/156) | 3.92 | 0.007705 | 0.047193 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.28% (2/156) | 3.92 | 0.007705 | 0.047193 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.28% (2/156) | 3.88 | 0.008165 | 0.047284 |
GO:0046390 | ribose phosphate biosynthetic process | 2.56% (4/156) | 2.35 | 0.008196 | 0.047356 |
GO:1902531 | regulation of intracellular signal transduction | 6.41% (10/156) | 1.3 | 0.007859 | 0.04802 |
GO:0070851 | growth factor receptor binding | 1.28% (2/156) | 3.84 | 0.008638 | 0.049793 |